This article was originally published in The Gray Sheet
AdvaMed sets its sights on achieving a floor vote for product liability reform, given the decreased likelihood of the measure passing with Medicare legislation this year. Rep. Jim Greenwood (R-Penn.) still hopes to attach his HEALTH ACT (HR 5) to the "Medicare Prescription Drug & Modernization Act" of 2003 prior to the House/Senate conference, anticipated after the July 4 recess...
You may also be interested in...
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.